Skip to main content

Table 1 FLAME patient population baseline characteristics

From: Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population

Baseline characteristics

Values

 Age at baseline, mean (SD), years

64.6 (7.8)

 Height, mean (SD), cm

169 (8.7)

 Weight, mean (SD), kg

73.9 (17.1)

 BMI, mean (SD), kg/m2

25.9 (5.2)

 Proportion males, n (%)

2557 (76.1)

Severity of COPD

 GOLD 1a, n (%)

0 (0.0)

 GOLD 2a, n (%)

1123 (33.7)

 GOLD 3a, n (%)

1954 (58.6)

 GOLD 4a, n (%)

257 (7.7)

 Group Ab, n (%)

2 (0.1)

 Group Bb, n (%)

822 (24.4)

 Group Cb, n (%)

3 (0.1)

 Group Db, n (%)

2514 (74.8)

Number of COPD exacerbations in the previous year

1.19

Current smokers, n (%)

1333 (39.6)

  1. BMI body mass index, COPD chronic obstructive pulmonary disease, GOLD global initiative for chronic obstructive lung disease, SD standard deviation
  2. aSeverity of airflow limitation based on 2011–2014 GOLD criteria; bBased on 2015 GOLD staging system